THC RSI Chart
Last 7 days
10.5%
Last 30 days
21.5%
Last 90 days
40.8%
Trailing 12 Months
78.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 20.9B | 0 | 0 | 0 |
2023 | 19.4B | 19.9B | 20.2B | 20.5B |
2022 | 19.4B | 19.1B | 19.0B | 19.2B |
2021 | 17.9B | 19.2B | 19.5B | 19.5B |
2020 | 18.5B | 17.5B | 17.5B | 17.6B |
2019 | 18.2B | 18.2B | 18.3B | 18.5B |
2018 | 20.1B | 19.4B | 19.0B | 18.3B |
2017 | 20.8B | 20.8B | 20.5B | 20.6B |
2016 | 20.7B | 21.1B | 21.3B | 21.1B |
2015 | 18.4B | 18.9B | 19.5B | 20.1B |
2014 | 13.8B | 15.5B | 17.3B | 17.9B |
2013 | 10.0B | 10.2B | 10.4B | 12.1B |
2012 | 9.4B | 9.6B | 9.7B | 9.9B |
2011 | 9.1B | 9.1B | 9.1B | 9.4B |
2010 | 8.9B | 8.9B | 8.9B | 9.0B |
2009 | 0 | 8.7B | 8.7B | 8.8B |
2008 | 0 | 0 | 0 | 8.6B |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 01, 2024 | arnst thomas w | sold | -945,994 | 116 | -8,148 | evp, chief admin. officer & gc |
Apr 05, 2024 | sutaria saumya | gifted | - | - | -125,000 | chairman & ceo |
Mar 12, 2024 | mark richard j | sold | -1,385,720 | 98.98 | -14,000 | - |
Mar 06, 2024 | arbour paola m | sold | -1,761,570 | 96.96 | -18,168 | evp, chief information officer |
Mar 01, 2024 | arnst thomas w | sold (taxes) | -207,721 | 94.29 | -2,203 | evp, chief admin. officer & gc |
Mar 01, 2024 | arnst thomas w | sold | -1,612,230 | 94.8373 | -17,000 | evp, chief admin. officer & gc |
Mar 01, 2024 | arbour paola m | sold (taxes) | -103,908 | 94.29 | -1,102 | evp, chief information officer |
Mar 01, 2024 | arbour paola m | acquired | - | - | 2,799 | evp, chief information officer |
Mar 01, 2024 | ramsey r. scott | acquired | - | - | 1,399 | principal accounting officer |
Mar 01, 2024 | ramsey r. scott | sold (taxes) | -32,152 | 94.29 | -341 | principal accounting officer |
Which funds bought or sold THC recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 06, 2024 | HighTower Advisors, LLC | added | 35.25 | 332,000 | 698,000 | -% |
May 06, 2024 | Mesirow Institutional Investment Management, Inc. | sold off | -100 | -16,170,500 | - | -% |
May 06, 2024 | Empowered Funds, LLC | new | - | 11,223,100 | 11,223,100 | 0.20% |
May 06, 2024 | LEUTHOLD GROUP, LLC | reduced | -0.05 | 989,710 | 3,525,920 | 0.40% |
May 06, 2024 | DiNuzzo Private Wealth, Inc. | unchanged | - | 414 | 1,472 | -% |
May 06, 2024 | Quantbot Technologies LP | sold off | -100 | -37,483 | - | -% |
May 06, 2024 | BANQUE PICTET & CIE SA | reduced | -8.74 | 1,319,050 | 6,217,570 | 0.06% |
May 06, 2024 | Leith Wheeler Investment Counsel Ltd. | reduced | -35.24 | -1,689,900 | 15,341,500 | 1.49% |
May 06, 2024 | LSV ASSET MANAGEMENT | reduced | -22.44 | 664,000 | 9,082,000 | 0.02% |
May 06, 2024 | Savant Capital, LLC | added | 29.1 | 211,584 | 477,516 | -% |
Unveiling Tenet Healthcare Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Tenet Healthcare Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 462.0B | 371.6B | 20.64 | 1.24 | ||||
CI | 98.5B | 206.0B | 25.56 | 0.48 | ||||
HCA | 82.4B | 66.7B | 15.06 | 1.23 | ||||
CVS | 70.0B | 360.9B | 9.55 | 0.19 | ||||
CNC | 40.5B | 155.5B | 14.81 | 0.26 | ||||
DVA | 12.1B | 12.3B | 14.8 | 0.98 | ||||
UHS | 11.7B | 14.3B | 16.37 | 0.82 | ||||
MID-CAP | ||||||||
CHE | 8.8B | 2.3B | 30.96 | 3.83 | ||||
ACHC | 6.3B | 3.0B | -553.66 | 2.09 | ||||
AMN | 2.3B | 3.8B | 10.82 | 0.6 | ||||
AMEH | 2.1B | 1.4B | 34.65 | 1.52 | ||||
SMALL-CAP | ||||||||
ADUS | 1.7B | 1.1B | 26.07 | 1.57 | ||||
BKD | 1.4B | 3.0B | -7.37 | 0.46 | ||||
BEAT | 54.0M | - | -3.69 | - | ||||
AMS | 19.6M | 21.3M | 36.7 | 0.92 |
Tenet Healthcare Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -0.2% | 5,368 | 5,379 | 5,066 | 5,082 | 5,021 | 4,990 | 4,801 | 4,638 | 4,745 | 4,856 | 4,894 | 4,954 | 4,781 | 4,915 | 4,557 | 3,648 | 4,520 | 4,806 | 4,568 | 4,560 | 4,545 |
EBITDA Margin | 76.5% | 0.29* | 0.16* | 0.16* | 0.16* | 0.16* | 0.16* | 0.17* | 0.19* | 0.19* | 0.19* | 0.20* | 0.15* | - | - | - | - | - | - | - | - | - |
Interest Expenses | -4.0% | 218 | 227 | 227 | 226 | 221 | 219 | 222 | 222 | 227 | 221 | 227 | 235 | 240 | 242 | 263 | 255 | 243 | 243 | 244 | 247 | 251 |
Income Taxes | 1090.5% | 750 | 63.00 | 79.00 | 80.00 | 84.00 | 47.00 | 112 | 86.00 | 99.00 | 108 | 197 | 61.00 | 45.00 | 130 | -197 | 45.00 | -75.00 | 85.00 | 22.00 | 33.00 | 20.00 |
Earnings Before Taxes | 494.2% | 3,084 | 519 | 345 | 373 | 380 | 321 | 380 | 265 | 378 | 528 | 774 | 319 | 267 | 676 | -304 | 214 | 85.00 | 209 | -125 | 152 | 84.00 |
EBT Margin | 162.8% | 0.21* | 0.08* | 0.07* | 0.07* | 0.07* | 0.07* | 0.08* | 0.10* | 0.10* | 0.10* | 0.10* | 0.05* | - | - | - | - | - | - | - | - | - |
Net Income | 411.8% | 2,334 | 456 | 266 | 293 | 296 | 274 | 268 | 179 | 280 | 419 | 578 | 257 | 222 | 546 | -106 | 169 | 159 | 124 | -146 | 121 | 72.00 |
Net Income Margin | 151.2% | 0.16* | 0.06* | 0.06* | 0.06* | 0.05* | 0.05* | 0.06* | 0.08* | 0.08* | 0.08* | 0.08* | 0.05* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -43.8% | 346 | 616 | 327 | 466 | 214 | 131 | 150 | -33.00 | 73.00 | 53.00 | 321 | 123 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 2.1% | 28,907 | 28,312 | 27,590 | 27,157 | 27,067 | 27,156 | 27,076 | 26,621 | 26,650 | 27,579 | 25,913 | 26,565 | 27,579 | 27,106 | 26,187 | 26,250 | 23,823 | 23,365 | 23,357 | 23,207 | 23,158 |
Current Assets | 9.1% | 7,821 | 7,167 | 6,359 | 5,995 | 5,869 | 5,981 | 5,998 | 6,064 | 6,128 | 1,176 | 6,905 | 7,417 | 6,699 | 1,309 | 7,808 | 7,947 | 5,388 | 1,180 | 4,789 | 4,704 | 4,582 |
Cash Equivalents | 102.0% | 2,481 | 1,228 | 1,054 | 934 | 766 | 858 | 1,208 | 1,351 | 1,405 | 2,364 | 2,292 | 2,194 | 2,141 | 2,446 | 3,300 | 3,514 | 613 | 262 | 314 | 249 | 252 |
Inventory | -3.9% | 395 | 411 | 413 | 404 | 407 | 405 | 394 | 387 | 391 | 384 | 376 | 364 | 368 | 368 | 349 | 337 | 324 | 310 | 311 | 309 | 308 |
Net PPE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7,001 | 6,995 | 6,996 |
Goodwill | 2.5% | 10,568 | 10,307 | 10,415 | 10,350 | 10,258 | 10,123 | 707 | 206 | 84.00 | 664 | 65.00 | 76.00 | 25.00 | 1,581 | 78.00 | 76.00 | 83.00 | 7,252 | 34.00 | 18.00 | 3.00 |
Liabilities | -6.9% | 21,236 | 22,804 | 22,409 | 22,156 | 22,262 | 22,548 | 22,501 | 22,510 | 22,236 | 23,322 | 22,230 | 23,362 | 23,546 | 24,217 | 24,186 | 24,056 | 21,794 | 21,422 | 21,393 | 21,028 | 21,045 |
Current Liabilities | 13.8% | 5,416 | 4,760 | 4,432 | 4,152 | 4,219 | 4,476 | 4,276 | 4,368 | 4,668 | 495 | 5,379 | 5,071 | 4,930 | 516 | 5,843 | 5,585 | 4,095 | 372 | 3,928 | 4,150 | 3,725 |
Long Term Debt | -14.2% | 12,772 | 14,882 | 14,901 | 14,907 | 14,935 | 14,934 | 14,962 | 14,947 | 14,719 | 15,511 | 14,009 | 15,091 | 15,098 | 15,574 | 15,561 | 15,728 | 15,082 | 14,580 | 14,858 | 14,312 | 14,814 |
Shareholder's Equity | 114.7% | 3,453 | 1,608 | 1,464 | 2,724 | 2,580 | 2,459 | 2,507 | 2,114 | 2,056 | 2,054 | 1,635 | 1,169 | 1,016 | 937 | 522 | 633 | 503 | 437 | 448 | 670 | 618 |
Retained Earnings | 1120.3% | 1,959 | -192 | -436 | -537 | -660 | -803 | -905 | -1,036 | -1,074 | -1,214 | -1,463 | -1,912 | -2,031 | -2,128 | -2,542 | -2,346 | -2,434 | -2,513 | -2,469 | -2,237 | -2,254 |
Additional Paid-In Capital | -0.6% | 4,806 | 4,834 | 4,818 | 4,800 | 4,774 | 4,778 | 4,771 | 4,756 | 4,765 | 4,877 | 4,862 | 4,854 | 4,841 | 4,844 | 4,826 | 4,751 | 4,739 | 4,760 | 4,751 | 4,755 | 4,748 |
Accumulated Depreciation | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5,645 | 5,526 | 5,382 |
Shares Outstanding | -2.0% | 100 | 102 | 102 | 102 | 102 | 107 | 108 | 108 | 107 | 107 | 107 | 107 | - | - | - | - | - | - | - | - | - |
Minority Interest | -1.3% | 1,490 | 1,509 | 1,414 | 1,381 | 1,347 | 1,317 | 1,272 | 1,027 | 1,000 | 659 | 913 | 908 | 893 | 621 | 896 | 890 | 861 | 579 | 830 | 825 | 808 |
Float | - | - | - | - | 6,400 | - | - | - | 5,600 | - | - | - | 5,400 | - | - | - | 1,100 | - | - | - | 1,200 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -28.9% | 586 | 824 | 503 | 598 | 449 | 421 | 315 | 119 | 228 | 357 | 432 | 245 | 534 | 446 | 593 | 2,239 | 129 | 520 | 419 | 284 | 10.00 |
Share Based Compensation | -5.6% | 17.00 | 18.00 | 15.00 | 19.00 | 14.00 | 9.00 | 13.00 | 18.00 | 16.00 | 13.00 | 13.00 | 16.00 | 14.00 | 6.00 | 11.00 | 14.00 | 13.00 | 8.00 | 11.00 | 12.00 | 11.00 |
Cashflow From Investing | 1099.4% | 3,328 | -333 | -169 | -181 | -286 | -306 | -302 | -140 | -60.00 | -1,516 | 997 | -50.00 | -145 | -1,202 | -117 | -85.00 | -204 | -193 | -123 | -164 | -139 |
Cashflow From Financing | -739.4% | -2,661 | -317 | -214 | -249 | -255 | -465 | -156 | -33.00 | -1,127 | 1,231 | -1,331 | -142 | -694 | -98.00 | -690 | 747 | 426 | -379 | -231 | -123 | -30.00 |
Buy Backs | 152.7% | 278 | 110 | - | 40.00 | 50.00 | 250 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Millions | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Net operating revenues | $ 5,368 | $ 5,021 |
Grant income | 0 | 3 |
Equity in earnings of unconsolidated affiliates | 59 | 50 |
Operating expenses: | ||
Salaries, wages and benefits | 2,321 | 2,258 |
Supplies | 928 | 891 |
Other operating expenses, net | 1,154 | 1,093 |
Depreciation and amortization | 208 | 217 |
Impairment and restructuring charges, and acquisition-related costs | 27 | 21 |
Litigation and investigation costs | 4 | 4 |
Net gains on sales, consolidation and deconsolidation of facilities | (2,500) | (13) |
Operating income | 3,285 | 603 |
Interest expense | (218) | (221) |
Other non-operating income (expense), net | 25 | (2) |
Loss from early extinguishment of debt | (8) | 0 |
Income before income taxes | 3,084 | 380 |
Income tax expense | (750) | (84) |
Net income | 2,334 | 296 |
Less: Net income available to noncontrolling interests | 183 | 153 |
Net income available to Tenet Healthcare Corporation common shareholders | $ 2,151 | $ 143 |
Earnings per share available to Tenet Healthcare Corporation common shareholders: | ||
Basic earnings per share ((in dollars per share) | $ 21.60 | $ 1.40 |
Diluted earnings per share (in dollars per share) | $ 21.38 | $ 1.32 |
Weighted average shares and dilutive securities outstanding (in thousands): | ||
Basic (in shares) | 99,581 | 102,289 |
Diluted (in shares) | 100,598 | 106,006 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 2,481 | $ 1,228 |
Accounts receivable | 3,148 | 2,914 |
Inventories of supplies, at cost | 395 | 411 |
Assets held for sale | 22 | 775 |
Other current assets | 1,775 | 1,839 |
Total current assets | 7,821 | 7,167 |
Investments and other assets | 3,244 | 3,157 |
Deferred income taxes | 20 | 77 |
Property and equipment, at cost, less accumulated depreciation and amortization ($5,908 at March 31, 2024 and $6,478 at December 31, 2023) | 5,855 | 6,236 |
Goodwill | 10,568 | 10,307 |
Other intangible assets, at cost, less accumulated amortization ($1,312 at March 31, 2024 and $1,447 at December 31, 2023) | 1,399 | 1,368 |
Total assets | 28,907 | 28,312 |
Current liabilities: | ||
Current portion of long-term debt | 107 | 120 |
Accounts payable | 1,335 | 1,408 |
Accrued compensation and benefits | 775 | 930 |
Professional and general liability reserves | 266 | 254 |
Accrued interest payable | 249 | 200 |
Liabilities held for sale | 11 | 69 |
Income tax payable | 805 | 23 |
Other current liabilities | 1,868 | 1,756 |
Total current liabilities | 5,416 | 4,760 |
Long-term debt, net of current portion | 12,772 | 14,882 |
Professional and general liability reserves | 794 | 792 |
Defined benefit plan obligations | 334 | 335 |
Deferred income taxes | 231 | 326 |
Other long-term liabilities | 1,689 | 1,709 |
Total liabilities | 21,236 | 22,804 |
Commitments and contingencies | ||
Redeemable noncontrolling interests in equity of consolidated subsidiaries | 2,728 | 2,391 |
Shareholders’ equity: | ||
Common stock, $0.05 par value; authorized 262,500 shares; 157,805 shares issued at March 31, 2024 and 157,271 shares issued at December 31, 2023 | 8 | 8 |
Additional paid-in capital | 4,806 | 4,834 |
Accumulated other comprehensive loss | (179) | (181) |
Retained earnings (accumulated deficit) | 1,959 | (192) |
Common stock in treasury, at cost, 60,132 shares at March 31, 2024 and 57,321 shares at December 31, 2023 | (3,141) | (2,861) |
Total shareholders’ equity | 3,453 | 1,608 |
Noncontrolling interests | 1,490 | 1,509 |
Total equity | 4,943 | 3,117 |
Total liabilities and equity | $ 28,907 | $ 28,312 |